Clinical Trial Update: Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating neoadjuvant FOLFOX6 chemotherapy with or without radiation for rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• FOLFOX6 chemotherapy regimen (FOLFOX6)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN